ClinicalTrials.Veeva

Menu

ArtontheBrain: An Inclusive Evidence-based Cognitive Health App for Older Adults to Promote Aging at Home

B

Baycrest

Status

Unknown

Conditions

Aging
Cognitive Impairment
Mild Cognitive Impairment
Age-related Cognitive Decline
Dementia

Treatments

Device: ArtontheBrain
Device: Seniors Online Victoria

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The research proposed here will evaluate whether a web-based recreation intervention, called ArtontheBrain, has positive health benefits to older adult users. ArtontheBrain incorporates three basic activities; learning (history of the artwork), play (telling stories, solving puzzles) and socializing with other users, either in person or online. It can be used alone, with another person, or in a group. It is modeled after participatory arts-based interventions which studies have shown are associated with health benefits in older adults, such as improved sense of well-being, physical health, decreased risk of dementia, and reduced need for health services. Our study will test ArtontheBrain at research sites and health agencies in Canada, the U.S., and the U.K. with older adults with and without cognitive decline. The study will also examine how well that app can support different user play modalities and whether it can effect positive health outcomes similar to face-to-face arts interventions.

Full description

Our project seeks to validate the positive health impacts of a mobile health (mhealth) intervention, called ArtontheBrain; a web-based application (app) aimed at promoting cognitive health in older adults, aging at home, through mentally and socially engaging recreation. The app was created in response to research showing: a) older adults with chronic health conditions experience reduced access to enjoyable recreation due to various barriers (e.g., sensory loss, cognitive decline, mobility limitations, geography and low mood); and b) participatory arts-based recreation is associated with health benefits in seniors (e.g., enhanced well-being, improved physical health, decreased risk of dementia, and reduced use of healthcare resources). There are limited evidence-based solutions for consumers and this clinical validation will provide information about the efficacy of ArtontheBrain in achieving positive health outcomes to guide health practitioners and older adult consumers toward proven products.

Based on quality of life (QOL) benefits for older adults, reported from participatory arts interventions, we hypothesize that engagement with ArtontheBrain will produce similar improvements in QOL in our study participants, driven by specific features of this type of intervention e.g., self-directed, flexible level of complexity, driven by the user. Secondary outcomes hypothesized for engagement with the intervention, include benefits to: active living, aspects of cognition (e.g., attention control, reasoning) and health seeking behaviours. These hypotheses are encouraged by findings from our initial pilot testing which showed improvement in self-perceived health-related QOL and reduced doctor visits in our pilot participants and established proof of principle for the ArtontheBrain with respect to positive user feedback on their experience with this recreation app.

Enrollment

110 estimated patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 60 years of age and older.

  2. Having normal or corrected to normal vision.

  3. Self-reported proficiency in English.

  4. Compliance with treatment, over the specified period of 6-weeks.

  5. Having experienced:

    1. Age-normal cognitive decline defined as having a Montreal Cognitive Assessment (MoCA) score ≥23 with no functional impairment in Instrumental Activities of Daily Living (iADLs), and no subjective memory complaint;
    2. MCI as defined as having a MoCA score ≤26 with no significant functional impairment in iADLs (e.g., no more than one iADL domain compromised), and report of memory decline by self or family member; or health professional.
    3. Early dementia as defined as MoCA score ≤23 with significant functional impairment in more than one iADLs domain.
  6. Having access to a computer (e.g., desktop, laptop, tablet) and internet.

Exclusion criteria

  1. Significant vision loss (low vision accepted).
  2. Non-fluent in English.
  3. Major psychiatric disorder.
  4. Neurological disorder causing aphasia or causing severe dementia.
  5. Motor limitations that prevent independent use of computer technology.
  6. Current history of substance abuse.
  7. No access to a computer (e.g., desktop, laptop, tablet) or internet.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

110 participants in 3 patient groups

ArtontheBrain
Experimental group
Description:
ArtontheBrain application for about 30 to 45 minutes twice per week, over 6 weeks.
Treatment:
Device: ArtontheBrain
Seniors Online Victoria
Active Comparator group
Description:
Senior Online Victoria games for about 30 to 45 minutes twice per week, over 6 weeks (https://www.seniorsonline.vic.gov.au/services-information/games), after which they will participate in the ArtontheBrain intervention.
Treatment:
Device: Seniors Online Victoria
Device: ArtontheBrain
Waitlist Control
Other group
Description:
The waitlist control group will no treatment for 6 weeks, after which they will six weeks of the ArtontheBrain intervention.
Treatment:
Device: ArtontheBrain

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems